Free Trial

Nuvei (NVEI) Stock Forecast & Price Target

Nuvei logo
$33.99 +0.01 (+0.03%)
(As of 11/15/2024 ET)

Nuvei - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
9
Buy
7

Based on 16 Wall Street analysts who have issued ratings for Nuvei in the last 12 months, the stock has a consensus rating of "Hold." Out of the 16 analysts, 9 have given a hold rating, and 7 have given a buy rating for NVEI.

Consensus Price Target

$32.08
-5.63% Downside
According to the 16 analysts' twelve-month price targets for Nuvei, the average price target is $32.08. The highest price target for NVEI is $34.00, while the lowest price target for NVEI is $27.00. The average price target represents a forecasted downside of -5.63% from the current price of $33.99.
Get the Latest News and Ratings for NVEI and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Nuvei and its competitors.

Sign Up

NVEI Analyst Ratings Over Time

TypeCurrent Forecast
11/17/23 to 11/16/24
1 Month Ago
10/18/23 to 10/17/24
3 Months Ago
8/19/23 to 8/18/24
1 Year Ago
11/17/22 to 11/17/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
7 Buy rating(s)
8 Buy rating(s)
8 Buy rating(s)
11 Buy rating(s)
Hold
9 Hold rating(s)
9 Hold rating(s)
9 Hold rating(s)
2 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$32.08$32.21$32.21$32.80
Forecasted Upside-5.63% Downside-4.07% Downside-2.94% Downside67.18% Upside
Consensus Rating
Hold
Hold
Hold
Moderate Buy

NVEI Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

NVEI Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Nuvei Stock vs. The Competition

TypeNuveiBusiness Services CompaniesS&P 500
Consensus Rating Score
2.44
2.68
2.50
Consensus RatingHoldModerate BuyModerate Buy
Predicted Upside-5.63% Downside329.78% Upside9.86% Upside
News Sentiment Rating
Neutral News

See Recent NVEI News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
5/8/2024JPMorgan Chase & Co.
3 of 5 stars
 DowngradeOverweight ➝ Neutral$32.00 ➝ $34.00+5.10%
4/3/2024Citigroup
3 of 5 stars
 Boost TargetNeutral ➝ Neutral$27.00 ➝ $34.00+5.39%
4/3/2024UBS Group
4 of 5 stars
 Reiterated RatingBuy ➝ Neutral$30.00 ➝ $34.00+5.39%
4/2/2024Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingSector Outperform ➝ Sector Perform$34.00+5.36%
4/2/2024Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$40.00 ➝ $34.00+4.91%
4/2/2024Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Peer Perform
4/2/2024Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Market Perform$31.00 ➝ $34.00+4.91%
4/1/2024William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
C. Kennedy
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Market Perform
3/7/2024BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$30.00 ➝ $28.00+17.15%
3/7/2024Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$27.00 ➝ $30.00+25.52%
3/7/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$29.00 ➝ $34.00+49.19%
3/7/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetEqual Weight ➝ Equal Weight$29.00 ➝ $27.00+18.47%
1/26/2024National Bankshares
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$23.00 ➝ $30.00+19.28%
1/11/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$21.00 ➝ $30.00+21.07%
12/20/2023Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOverweight$34.00+33.39%
11/30/2023Seaport Res Ptn
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Cantwell
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy
11/9/2023CIBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$30.00 ➝ $34.00+75.98%
8/10/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$44.00 ➝ $36.00+98.57%
8/10/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$42.00 ➝ $26.00+43.41%
4/11/2023Sumitomo Mitsui Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Outperform$50.00 ➝ $55.00+36.21%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 04:48 PM ET.


NVEI Forecast - Frequently Asked Questions

According to the research reports of 16 Wall Street equities research analysts, the average twelve-month stock price forecast for Nuvei is $32.08, with a high forecast of $34.00 and a low forecast of $27.00.

16 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Nuvei in the last twelve months. There are currently 9 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" NVEI shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NVEI, but not buy additional shares or sell existing shares.

According to analysts, Nuvei's stock has a predicted downside of -5.63% based on their 12-month stock forecasts.

Analysts like Nuvei less than other "business services" companies. The consensus rating for Nuvei is Hold while the average consensus rating for "business services" companies is Moderate Buy. Learn more on how NVEI compares to other companies.


This page (NASDAQ:NVEI) was last updated on 11/16/2024 by MarketBeat.com Staff
From Our Partners